Reni Benjamin analyst JMP

Currently out of the existing stock ratings of Reni Benjamin, 143 are a BUY (91.08%), 13 are a HOLD (8.28%), 1 are a SELL (0.64%).

Reni Benjamin

Work Performance Price Targets & Ratings Chart

Analyst Reni Benjamin, employed at JMP, carries an average stock price target met ratio of 43.58% that have a potential upside of 50.23% achieved within 177 days on average.

Reni Benjamin’s has documented 297 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BPMC, Blueprint Medicines Corp at 07-Jun-2024.

Wall Street Analyst Reni Benjamin

Analyst best performing recommendations are on CTIC (CTI BIOPHARMA CORP).
The best stock recommendation documented was for CTIC (CTI BIOPHARMA CORP) at 3/2/2022. The price target of $5 was fulfilled within 23 days with a profit of $1.63 (48.37%) receiving and performance score of 21.03.

Average potential price target upside

BCYC Bicycle Therapeutics Ltd BPMC Blueprint Medicines Corp DCPH Deciphera Pharmaceuticals LLC EFTR Effector Therapeutics INBX Inhibrx  INCY yte IOVA Iovance Biotherapeutics SGEN Seagen STRO Sutro Biopharma VYGR Voyager Therapeutics ALLO Allogene Therapeutics CGEN Compugen KURA Kura Oncology ACET Adicet Bio CTIC CTi Biopharma Corp RGNX Regenxbio ADAP Adaptimmune Therapeutics Plc ADVM Adverum Biotechnologies BCAB Bioatla  CUE Cue Biopharma SPPI Spectrum Pharmaceuticals URGN UroGen Pharma Ltd AMAM Ambrx Biopharma . American Depositary Shares LVTX LAVA Therapeutics NV SANA Sana Biotechnology VSTM Verastem

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

55

$31.9 (138.10%)

55

1 months 14 days ago

1/8 (12.5%)

$30.42 (123.76%)

83

Buy

43

$19.9 (86.15%)

43

3 months 27 days ago

0/11 (0%)

$19.8 (85.34%)

Buy

32

$8.9 (38.53%)

44

5 months 28 days ago

1/9 (11.11%)

$13.92 (76.99%)

174

Buy

65

$41.9 (181.39%)

65

7 months 9 days ago

0/5 (0%)

$49.66 (323.73%)

40

$16.9 (73.16%)

42

7 months 14 days ago

0/5 (0%)

$24.47 (157.57%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Reni Benjamin is most bullish on?

Potential upside of $19.45 has been obtained for BPMC (BLUEPRINT MEDICINES CORP)

Which stock is Reni Benjamin is most reserved on?

Potential downside of -$0 has been obtained for INBX (INHIBRX )

What Year was the first public recommendation made by Reni Benjamin?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?